In a Bowen Technique session, the patient lies on a bed, wearing loosely fitting clothing, and relaxes, while the therapist applies a specifically located series of gentle movements across the body. The movements are composed of a challenge to a body of   more »

The AFFIRM and SENTINEL studies showed that natalizumab was effective both as monotherapy and in combination with interferon beta (IFNbeta)-1a in patients with relapsing multiple sclerosis (MS). Further analyses of AFFIRM and SENTINEL data were conducted to determine   more »

Similarities in the onset age of progression in secondary-progressive (SP) and primary-progressive multiple sclerosis (PPMS) have been previously reported. However, with longer follow-up, more relapsing-remitting (RRMS) patients reach SPMS, such   more »

Bayer will launch a titration pack for patients with multiple sclerosis (MS) that is specially designed to make it easier for them to start Betaferon® / Betaseron (interferon beta-1b) therapy. From now on, the titration pack will be available in   more »

Taken just once a week, AVONEX is the multiple sclerosis (MS) treatment that people stay on longer. So when you're thinking about multiple sclerosis treatments, choose AVONEX. AVONEX empowers   more »

Children with MS have been shown to have a significantly increased likelihood, relative to healthy age-matched peers, of being previously infected with Epstein-Barr virus (EBV) (Alotaibi et al., 2004). EBV infection leads to persistent B-cell infection, and B-cells are known to play a role in MS. Study of children enrolled   more »

Biogen Idec, Elan's partner in the development and sale of Tysabri, is testing the efficacy of a malaria pill developed during the Vietnam war in treating progressive multifocal leukoencephalopathy (PML), the brain infection that has been tied to use of Tysabri, according to Al Sandrock, Biogen's head of neurology   more »

Multiple sclerosis (MS) in children is being recognized with increasing frequency. The first descriptions of MS in children were published by Charcot between 1829 and 1849, though it was not for another 50 years that MS in children was again described in the literature (Hanefeld, 2007). There are now several national programs focused   more »

I would like to explain to you why I haven’t posted very many articles on my blog for the past few months. I had a relapse in October 2008 and just could not seem to get my sluggish brain to do any research with any amount of understanding. Then came Christmas and all the hubbub over   more »

The following questions ask for your views about the impact of MS on your day-to-day life during the past two weeks   more »

Was your MRI of your brain or you spine as well? Many MRI’s as done of only the brain where there may not be lesions. An MRI done of both the brain and the spine is much more definitive of MS.   more »

Did you know multiple sclerosis (MS) affects approximately 400,000 Americans and is the leading cause of neurological disability in young adults? As all currently available treatments for MS are given through injections or infusions many patients are anxiously awaiting an oral treatment option   more »

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt Germany, and Fast Forward, LLC, a wholly-owned subsidiary of the US National Multiple Sclerosis Society, announced a collaborative partnership to evaluate and fund promising multiple sclerosis (MS)   more »

Laquinimod drug trials for RRMS   more »

Infectious mononucleosis (called "mono" for short) is caused by the Epstein-Barr virus (EBV), a virus that affects nearly everybody at some point. The disease is sometimes known as glandular fever, because it causes lymph glands to   more »